• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

On 3 legs shall we stand: Combined innovation for treatment of ischemic cardiomyopathy.

作者信息

Kawabori Masashi, Hironaka Camille E, Chen Frederick Y

机构信息

Division of Cardiac Surgery, CardioVascular Center, Tufts Medical Center, Boston, Mass.

出版信息

JTCVS Open. 2021 May 6;7:223-227. doi: 10.1016/j.xjon.2021.03.025. eCollection 2021 Sep.

DOI:10.1016/j.xjon.2021.03.025
PMID:36003753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9390607/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/792d/9390607/bdd48ed667a0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/792d/9390607/d224f1004739/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/792d/9390607/bdd48ed667a0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/792d/9390607/d224f1004739/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/792d/9390607/bdd48ed667a0/gr1.jpg

相似文献

1
On 3 legs shall we stand: Combined innovation for treatment of ischemic cardiomyopathy.我们将依靠三条支柱：缺血性心肌病治疗的联合创新。
JTCVS Open. 2021 May 6;7:223-227. doi: 10.1016/j.xjon.2021.03.025. eCollection 2021 Sep.
2
Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: factors that influence survival.缺血性心肌病并缺血性二尖瓣反流患者的二尖瓣反流手术：影响生存的因素。
J Thorac Cardiovasc Surg. 2011 Nov;142(5):995-1001. doi: 10.1016/j.jtcvs.2011.07.044. Epub 2011 Aug 19.
3
Decision support in surgical management of ischemic cardiomyopathy.决策支持在缺血性心肌病的外科治疗中的应用。
J Thorac Cardiovasc Surg. 2010 Feb;139(2):283-93, 293.e1-7. doi: 10.1016/j.jtcvs.2009.08.055.
4
POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial.观点：在中度缺血性二尖瓣反流患者中，冠状动脉旁路移植术联合二尖瓣限制性瓣环成形术的疗效：一项随机试验。
J Thorac Cardiovasc Surg. 2009 Aug;138(2):278-85. doi: 10.1016/j.jtcvs.2008.11.010. Epub 2009 May 31.
5
Outcomes of coronary artery bypass grafting and reduction annuloplasty for functional ischemic mitral regurgitation: a prospective multicenter study (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve).冠状动脉旁路移植术和二尖瓣成形环缩术治疗功能性缺血性二尖瓣反流的结果：一项前瞻性多中心研究（非体外循环二尖瓣修复手术治疗的随机评估）。
J Thorac Cardiovasc Surg. 2011 Jan;141(1):91-7. doi: 10.1016/j.jtcvs.2010.08.057.
6
Repair or replace ischemic mitral regurgitation during coronary artery bypass grafting? A meta-analysis.冠状动脉搭桥手术中修复还是置换缺血性二尖瓣反流？一项荟萃分析。
J Cardiothorac Surg. 2016 Sep 1;11(1):141. doi: 10.1186/s13019-016-0536-6.
7
Surgical coronary revascularization with or without mitral valve repair of severe ischemic dilated cardiomyopathy.伴有或不伴有二尖瓣修复术的严重缺血性扩张型心肌病的外科冠状动脉血运重建术。
Heart Surg Forum. 2005;8(3):E146-50. doi: 10.1532/hsf98.20041036.
8
Does the additive risk of mitral valve repair in patients with ischemic cardiomyopathy prohibit surgical intervention?缺血性心肌病患者二尖瓣修复的附加风险是否会妨碍手术干预？
Ann Surg. 2000 May;231(5):710-4. doi: 10.1097/00000658-200005000-00011.
9
Differential Impact of Mitral Valve Repair on Outcome of Coronary Artery Bypass Grafting With or Without Surgical Ventricular Reconstruction in the Surgical Treatment for Ischemic Heart Failure (STICH) Trial.二尖瓣修复对缺血性心力衰竭外科治疗（STICH）试验中冠状动脉旁路移植术（无论是否行手术心室重建）结局的不同影响
Struct Heart. 2019;3(4):302-308. doi: 10.1080/24748706.2019.1610201. Epub 2019 May 23.
10
Coronary artery bypass grafting in the presence of valvular disease.瓣膜病存在时的冠状动脉旁路移植术。
Circulation. 1989 Jun;79(6 Pt 2):I182-4.

引用本文的文献

1
Commentary: Combination surgery for ischemic cardiomyopathy: The preemptive strike.评论：缺血性心肌病的联合手术：先发制人。
JTCVS Open. 2021 Mar 24;7:228-229. doi: 10.1016/j.xjon.2021.03.014. eCollection 2021 Sep.

本文引用的文献

1
Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease.特定人群和跨种族全基因组分析确定了冠心病的独特和共同遗传风险位点。
Nat Genet. 2020 Nov;52(11):1169-1177. doi: 10.1038/s41588-020-0705-3. Epub 2020 Oct 5.
2
Neonatal heart regeneration: Moving from phenomenology to regenerative medicine.新生儿心脏再生：从现象学迈向再生医学。
J Thorac Cardiovasc Surg. 2020 Jun;159(6):2451-2455. doi: 10.1016/j.jtcvs.2019.11.140. Epub 2020 Feb 19.
3
Natural Heart Regeneration in a Neonatal Rat Myocardial Infarction Model.
新生大鼠心肌梗死模型中的自然心脏再生。
Cells. 2020 Jan 16;9(1):229. doi: 10.3390/cells9010229.
4
On the Road to Regeneration: "Tools" and "Routes" Towards Efficient Cardiac Cell Therapy for Ischemic Cardiomyopathy.迈向心脏再生之路：改善缺血性心肌病心脏细胞治疗的“工具”和“途径”。
Curr Cardiol Rep. 2019 Oct 31;21(11):133. doi: 10.1007/s11886-019-1226-5.
5
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match.国际心肺移植学会国际胸科器官移植登记处：2019年第36份成人心脏移植报告；重点主题：供体与受体大小匹配
J Heart Lung Transplant. 2019 Oct;38(10):1056-1066. doi: 10.1016/j.healun.2019.08.004. Epub 2019 Aug 10.
6
Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.心肌活力与缺血性心肌病的长期预后
N Engl J Med. 2019 Aug 22;381(8):739-748. doi: 10.1056/NEJMoa1807365.
7
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial.心肌内注射间充质前体细胞并成功从左心室辅助装置支持中临时撤机治疗晚期心力衰竭患者：一项随机临床试验。
JAMA. 2019 Mar 26;321(12):1176-1186. doi: 10.1001/jama.2019.2341.
8
Stem Cell Therapy for Heart Failure: An Unfulfilled Promise?心力衰竭的干细胞治疗：一个未实现的承诺？
JAMA. 2019 Mar 26;321(12):1186-1187. doi: 10.1001/jama.2019.2617.
9
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.《2019年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
10
A Unique Collateral Artery Development Program Promotes Neonatal Heart Regeneration.一种独特的侧支动脉发育方案促进新生儿心脏再生。
Cell. 2019 Feb 21;176(5):1128-1142.e18. doi: 10.1016/j.cell.2018.12.023. Epub 2019 Jan 24.